«We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study,» Neuralink said
Tesla and SpaceX CEO Elon Musk has said that his brain-computer interface company Neuralink is likely to begin the first human trial this year.
Addressing the VivaTech trade fair in Paris late on Friday, Musk said that «it’s looking like the first case will be later this year».
Last month, Neuralink received US Food and Drug Administration (FDA) approval to begin its first-in-human clinical study, which means that actual humans could have a Neuralink device implanted in their heads.
